Researchers based at the Nuffield Department of Clinical Neurosciences, The John Radcliffe Hospital, University of Oxford, have reported a new study on the mechanism of… Read More »AAV treatment or surgical issues on chorioretinal atrophy? Researchers report on a study on potential adverse events in a gene therapy treatment.
Researchers based at the Department of Biomedical Engineering, University of Houston, Texas and the Department of Ophthalmology, Duke University Medical Centre, Durham, North Carolina, have… Read More »Maintaining proper RHO:PRPH2 ratios in photoreceptors may provide a potential therapeutic approach for intervention.
Researchers based at the MRC Human Genetics Unit, at the University of Edinburgh, and the Western General Hospital (Edinburgh), have reported a new study indicating… Read More »X-linked retinitis pigmentosa (XLRP) due to RPGR variants report new data on actin dynamics.
A consortium of researchers across Australia, New Zealand, USA, Italy, Portugal, Singapore, Netherlands, Taiwan and Canada, have reported a new study evaluating clinical, electrophysiological and… Read More »Variants in peripherin 2 (PRPH2 gene) shows genetic, functional and clinical observations on 241 IRD patients.
Researchers at the RIKEN BioResource Research Center, Kyoto, Japan, have reported that retinal organoids, derived from patients’ induced pluripotent stem cells (iPSCs) with a EYS… Read More »Retinal dystrophy caused by EYS dysfunction in retinal organoids shows significant phototoxicity from RIKEN research.
Researchers at the Department of Ophthalmology, University of Turin, Italy, have reported a significant association between OCT biomarker measurements and reading performance in patients with… Read More »Association of retinal OCT biomarkers with reading performance in patients with diabetic macular edema (DME).
Researchers at the Moorfields Eye Hospital and UCL Institute of Ophthalmology, University College London, UK, have reported the natural history of a retinopathy associated with… Read More »Natural history and characteristics of IQCB1(NPHP5) retinopathy may aim to measure relevant subsequent research outcomes.
Researchers at the Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, has reported an artificial intelligence (AI) tool, as a “large… Read More »AI responses (“chatbots”) compare favourably against ophthalmic specialists (human) using a “large language model” [LLM] for retinal and glaucoma diseases.
Researchers at the Department of Ophthalmology, at The Hebrew University of Jerusalem, have reported a new comprehensive analysis on Best disease patients, aimed to document… Read More »Mutations, analysis and genotype-phenotype results from the largest cohort of Best disease patients in the Israeli population and worldwide.
An international consortium of clinical researchers, led by Prof. Robert MacLaren, based in Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, UK, has reported… Read More »An international consortium report the largest, longest and comprehensive natural history study of choroideremia – a rare X-linked degenerative retinopathy.
